AN2 Therapeutics, Inc. , a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced its submission ...

Leading German laboratories ProGraphite and Dorfner Anzaplan have confirmed Kasiya Rutile- Graphite Project qualification for refractory applications. Sovereign Metals Limited, the firm behind the ...

ASX-listed Sovereign Metals has reported that testwork completed on graphite from its Kasiya rutile/graphite project, in Malawi, has confirmed that the project’s graphite has the key characteristics ...

Sovereign Metals has confirmed that graphite concentrate from its Kasiya project in Malawi is of refractory-grade quality. Refractories, the heat resistant ...

(Alliance News) - Sovereign Metals Ltd on Wednesday said testing has confirmed that graphite from its Kasiya rutile-graphite project in Malawi meets the requirements for use in refractory applications ...

Background Treatment strategies for Crohn’s disease (CD) suppress diverse inflammatory pathways but many patients remain ...

SOUTH SAN FRANCISCO - Allogene Therapeutics, Inc. (NASDAQ:ALLO), a biotechnology firm specializing in allogeneic CAR T therapies currently valued at approximately $299 million, has published new data ...

Sales of the firm's cell therapy franchise grew modestly in the fourth quarter amid competing product launches and overall slow uptake within the class.

Synthetic materials are made from natural resources. Synthetic materials are made by chemically changing the starting substances to create a material with different characteristics. Some examples of ...